Challenging Cases in NTM-LD: Treating Refractory MAC and Mitigating Adverse Events

196-21-635-VL-004 title concept

Activity Overview

In this 15-minute activity, an expert panel comprised of 2 pulmonologists and a pulmonology advanced practice provider discuss the management of 2 challenging cases of Mycobacterium avium complex (MAC) lung disease. The panel will provide privileged insights into strategies for controlling refractory MAC lung disease, highlighting their unique roles in the interprofessional management of treatment-related adverse events.

0.25 CE Credit(s)
Expires: November 23, 2022

Target Audience

This activity is intended for pulmonology and infectious disease clinicians (MD/NP/PA) who manage patients with nontuberculous mycobacterial lung disease (NTM-LD).

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Develop personalized treatment strategies for NTM-LD based on current data, guidelines, and best practices
  • Integrate the unique roles and responsibilities of the interprofessional care team members when managing NTM-LD

Activity Faculty

Philley_300x400

Julie V. Philley, MD

Executive Vice President, Health Affairs
University of Texas Health Science Center at Tyler
Tyler, TX

Daley_Charles - 300px

Charles L. Daley, MD

Chief, Division of Mycobacterial and Respiratory Infections
National Jewish Health
Professor, Medicine
National Jewish Health, the University of Colorado and Icahn School of Medicine at Mt. Sinai
Denver, CO

Sadler

Tara Sadler, APRN, MSN, FNP-C

Advanced Practice Provider
Pulmonary Clinic
University of Texas at Tyler Health Science Center
Tyler, TX